SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced that its subsidiary, Dako Denmark A/S, has received a close-out letter from the U.S. Food and Drug Administration with respect to the warning letter issued Aug. 21, 2013. The FDA informed Dako Denmark that it has completed its evaluation of Dako’s corrective actions and that it appears Dako has addressed the violations contained in the warning letter. The warning letter, issued by the FDA’s Center for Devic
| < Prev | Next > |
|---|
